Calcium carbonate
Regulatory activity · FDAAlso known as Advanced Formula Di-Gel, Alka-Mints, Alkets, Alkums+91 more
Advanced Formula Di-Gel, Alka-Mints, Alkets, Alkums, Amilac, CALCITE, CI 77220, Cal Gest, Cal Oys, Cal-Gest, Cal-Quick, Calafol Rx, Calcarb, Calcarb with D, Calcarea carbonica, Calci-Chew, Calci-Mix, Calcitab, Caltrate, Caltrate 600 with Iron and Vitamin D, Caltrate Plus D, Caltro, Carbonato de calcio, Children's Mylicon, Chooz, D-Cal, Dicarbosil, Duo Fusion, Encora AM Tablet, Encora PM Tablet, Equilet, Florical, Folbecal, Folgard OS, FoliNatal Plus B, Gas-X Total Relief, Gas-X with Maalox, HYDROLYZED PEARL, Healthy Mama, Kalziumkarbonat, Kohlensaurer kalk, Lactocal, Maalox Antacid Barrier, Maalox Children's, Maalox Max Quick Dissolve, Maalox Quick Dissolve, Maalox Quick Dissolve Maximum Strength, MagneBind, MagneBind 400 Rx, Marblen, Mi-Acid Double Strength, Monocal, Mylicon Children's, Nephro Calci, Nutralox, Os-Cal 500 + D, Os-Cal 500 with D, OsCal 500, Osteo-Poretical, Ostercal-D, Oysco 500, Oysco 500 with D, Oysco D, Oyst Cal, Oyst Cal 500, Pepcid Complete, Pepto-Bismol Children's, Phazyme Gas & Acid, Phazyme Gas And Acid, Premesis Rx, Prenatal Rx 1, Rolaids, Rolaids Reformulated Aug 2006, Slow-Mag, Slow-Mag Reformulated Feb 2012, Surpass, Titralac, Titralac Plus, Tums, Tums Dual Action, Tums Gas Relief, Tums with Gas Relief, Uni-Cal 500, Uni-Mint, Calcio carbonato, Antacid (Calcium Carbonate), CALCIUM (AS CALCIUM CARBONATE), CALCIUM (AS CARBONATE), Calcium Carbonate with Vitamin D3, Calcium carbonate (1:1), Calciumcarbonat, Carbonate de calcium, Carbonic acid calcium salt (1:1), Oysco D with Calcium, Viactiv Calcium Plus D.
Recent clinical, regulatory, research and industry developments relating to this drug.
The link between seawater and foraminiferal calcite chemistry
Dual clumped isotopes in foraminiferal calcite reveal kinetic bias in some species
Recall (Class II): CALCIUM CARBONATE
Calcium Carbonate to Augment Labor Contractions
Pharmacokinetics of Oral Calcium Carbonate in Parturients
Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
Phosphate and carbonate salts of calcium support robust bone building in osteoporosis.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- Annals of internal medicine1
- The American journal of clinical nutrition1
- The Journal of pharmacy and pharmacology1
- Brown TT1
- Butterfield K1
- Chan ES1
- East L1
- Hardin WR1
- Heaney RP1
- Hernandez-Illas M1
- Krishna R1
- Case Western Reserve University1
- Columbia University Medical Center1
- Duke University Community Advisory Board1
- Harvard School of Public Health1
- Hospital of the University of Pennsylvania1
- Johns Hopkins University School of Medicine1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.